Erasca, Inc. (ERAS)
11.60
+0.48
(+4.36%)
USD |
NASDAQ |
May 21, 16:00
11.61
0.00 (0.00%)
After-Hours: 19:59
Erasca EPS Diluted (Quarterly) : -0.6028 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -2.291 |
| Tango Therapeutics, Inc. | -0.317 |
| Scholar Rock Holding Corp. | -0.829 |
| Kymera Therapeutics, Inc. | -0.7098 |
| Relay Therapeutics, Inc. | -0.4075 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -183.44M |
| Total Expenses (Quarterly) | 183.44M |
| Enterprise Value | 3.411B |
| Earnings Yield | -8.04% |
| Normalized Earnings Yield | -4.863 |